Home/Filings/4/0001209191-17-031086
4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-17-031086

$TCRTCIK 0001107421operating

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:50 PM ET

Size

4.9 KB

Accession

0001209191-17-031086

Insider Transaction Report

Form 4
Period: 2017-05-05
Cooper Laurence James Neil
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2017-05-05$7.12/sh132,000$939,8401,077,291 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001107421

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:50 PM ET
Size
4.9 KB